Analyst access →

A SAFT Price Is Not a Token Valuation

Pre-TGE underwriting should value the security actually purchased, not a hypothetical liquid token. Rights, dilution, launch dependency and liquidity convert headline FDV into a contingent claim.

## The category error

A pre-token investment is often discussed as though it were a discounted purchase of an already functioning asset. It is not. A SAFT is a contractual claim on future tokens, while the referenced fully diluted valuation is usually the product of a token price and an assumed future supply. Neither term, by itself, establishes what the investor owns today or what that claim will be worth when it becomes transferable.

This distinction matters because a token’s economic properties can change materially between financing and launch. Supply may be revised, utility may remain incomplete, governance may be concentrated and transfer restrictions may outlast the token generation event. The headline valuation therefore compresses several unresolved questions into one apparently precise number.

The appropriate institutional approach is to separate three objects: the present value of the project, the eventual value of the token network and the value of the investor’s specific contractual claim. They may converge after launch, but they should not be treated as equivalent before it.

## Start with the claim, not the FDV

Pre-TGE analysis should begin with the legal and economic rights in the instrument. The central question is not simply how many tokens the SAFT promises. It is whether the agreement defines the relevant denominator, protects the allocation from later changes and provides a credible remedy if the anticipated issuance does not occur as expected.

A token entitlement stated as a percentage can be more robust than a fixed quantity only if the percentage has a clear reference set. A percentage of genesis supply, total supply or fully diluted supply can produce different outcomes. A fixed token amount appears certain, but it can be diluted by a later increase in supply or by additional instruments issued before launch. Definitions therefore carry more valuation weight than presentation format.

The same principle applies to conversion mechanics. A discount to a future round or token reference price has little meaning if the future price is set through a small, restricted or strategically managed transaction. A valuation cap can protect against price appreciation while offering no protection against supply expansion. Institutional underwriting should model both price and denominator risk rather than treating either as fixed.

## Replace point valuation with contingent value

A pre-TGE claim is better understood as a probability-weighted contingent asset. Its value depends on at least four transitions: the project must reach launch, the holder must receive the expected allocation, the token must become transferable and the market must support realizable liquidity. Failure at any stage can impair value even where the underlying development effort continues.

This framework does not require false precision. A scenario analysis can distinguish an on-time launch, a delayed launch, an altered token design and no qualifying issuance. Each scenario should apply its own supply base, vesting schedule, expected token utility and liquidity discount. The output should be a range of claim values rather than a single implied FDV.

Time is particularly important. A nominal discount to the expected launch price can disappear once vesting, delay and opportunity cost are incorporated. Tokens delivered over several years do not have the same present value as freely transferable tokens at launch. Nor should restricted tokens be marked at the full spot price when the holder cannot sell and circulating supply is temporarily scarce.

## Dilution extends beyond token count

Token dilution is usually presented as an increase in supply, but economic dilution is broader. A holder can retain the same percentage of supply while losing value if governance rights weaken, fee flows are redirected, staking rewards are changed or the token’s role is reduced. Conversely, an issuance can increase nominal supply without proportionate impairment if it finances activity that strengthens demand for the token. The relevant issue is not issuance alone, but the relationship between issuance and the token’s economic claim.

Controller discretion therefore deserves an explicit valuation charge. Where a foundation, company or governance body can amend emissions, treasury deployment, eligibility rules or token utility, investors are underwriting a decision process as well as a network. That discretion may be necessary before product-market fit, but flexibility for the issuer is uncertainty for the holder.

A credible model should map every material allocation: team, investors, ecosystem, treasury, community incentives and prospective future financing. It should then distinguish contractual supply from effective supply. Treasury tokens may not circulate immediately, but they remain an overhang if their deployment is discretionary. Locked allocations are not absent; they are deferred.

## Liquidity is part of valuation

Pre-TGE pricing often applies private-market logic to an asset expected to trade publicly. That combination can obscure the cost of market formation. A token can have a quoted price without offering institutional liquidity, particularly when initial float is small and most supply is locked. In that setting, spot price may describe the marginal trade rather than the realizable value of a large vested position.

The appropriate discount should reflect expected float, concentration, venue quality, market-making arrangements, unlock timing and the investor’s own position size. It should not assume that current holders can exit at the price used to calculate FDV. A high headline valuation supported by a thin float can coexist with a much lower liquidation value for SAFT recipients.

This is also why low initial circulating supply should not automatically be interpreted as scarcity. It may support price in the short term while increasing the valuation gap between circulating market capitalization and the claims scheduled to enter the market. The larger that gap, the more important unlock sequencing becomes to underwriting.

## Terms can create more value than a lower price

A cheaper SAFT is not necessarily the better security. Stronger terms can dominate a larger headline discount when they reduce denominator risk, delivery uncertainty or adverse selection at launch. Useful protections include precise supply definitions, treatment of subsequent token instruments, information rights, clear delivery deadlines and remedies for material changes to the token design.

Most-favoured treatment can be valuable, but only if it covers economically comparable instruments rather than nominally identical contracts. Side letters, warrants, advisory allocations and market-making agreements may alter the effective price paid by other participants without changing the face terms of their SAFTs. The review must therefore encompass the full pre-launch capital structure.

The same scrutiny should apply to vesting. Lockups that align insiders and investors can support market quality, yet asymmetrical schedules can subordinate one group to another. Vesting should be assessed alongside launch float and treasury discretion, not as an isolated calendar.

## Underwrite the bridge between company and network

The final complication is that development frequently occurs through a company or foundation, while value is expected to accrue to a token. Funding the entity does not guarantee value capture by the token, and owning future tokens does not necessarily provide a claim on the entity’s revenue, intellectual property or treasury.

Pre-TGE diligence must therefore identify the bridge between enterprise activity and token demand. That bridge may consist of fees, staking requirements, collateral use, governance authority or another enforceable role. If the connection is discretionary or purely promotional, traditional operating progress may not translate into token value.

The resulting discipline is straightforward: value the instrument actually purchased, model the token that may exist and test the mechanism connecting project success to token-holder outcomes. Headline FDV is then a reference point, not the conclusion. In pre-TGE markets, the largest valuation errors arise not from choosing the wrong multiple, but from valuing the wrong asset.